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Transforming growth factor (TGF)-h3 is an important contributor to the regulation of medial edge epithelium (MEE) disappearance
during palatal fusion. SMAD2 phosphorylation in the MEE has been shown to be directly regulated by TGF-h3. No phospho-SMAD2 was
identified in the MEE in Tgf-h3-null mutant mice (Tgf-h3/), which was correlated with the persistence of the MEE and failure of palatal
fusion. In the present study, the cleft palate phenotype in Tgf-h3/ mice was rescued by overexpression of a Smad2 transgene in Keratin 14-
synthesizing MEE cells following mating Tgf-h3 heterozygous mice with Keratin 14 promoter directed Smad2 transgenic mice (K14-
Smad2). Success of the rescue could be attributed to the elevated phospho-SMAD2 level in the MEE, demonstrated by two indirect
evidences. The rescued palatal fusion in Tgf-h3//K14-Smad2 mice, however, never proceeded to the junction of primary and secondary
palates and the most posterior border of the soft palate, despite phospho-SMAD2 expression in these regions at the same level as in the
middle portion of the secondary palate. The K14-Smad2 transgene was unable to restore all the functional outcomes of TGF-h3. This may
indicate an anterior–posterior patterning in the palatal shelves with respect to TGF-h3 signaling and the mechanism of secondary palatal
fusion.
D 2004 Elsevier Inc. All rights reserved.
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RescueIntroduction
Transforming growth factor (TGF)-h3 has been shown to
play an important role in the events regulating the disappear-
ance of the medial edge epithelium (MEE) during palatal
fusion. Tgf-h3-null mutant (Tgf-h3/) mice have a cleft
palate that is the principal developmental defect visualized at
birth in these mice (Kaartinen et al., 1995; Proetzel et al.,
1995). Previous studies suggested that all Tgf-h3/ mice
exhibited cleft palate, however, the severity of the cleft varied
between different mouse genetic backgrounds (Kaartinen et
al., 1995; Koo et al., 2001; Proetzel et al., 1995). The cleft
palate phenotype was most severe on the C57BL/6 back-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: shuler@usc.edu (C.F. Shuler).ground, in which about 50% of Tgf-h3/ mice had a
complete cleft while the remainder had partial clefts. Thus,
Tgf-h3 knockout mice with a C57BL/6 background have
been most often used in the analysis of secondary palate
development (Blavier et al., 2001; Cui et al., 2003; Gato et al.,
2002; Kaartinen et al., 1997; Martı´nez-A´lvarez et al.,
2000a,b; Taya et al., 1999).
The TGF-h family initiates signaling by triggering a
phosphorylation cascade initiated by TGF-h receptors
(ThRs) and members of the SMAD family. SMAD2/3 are
phosphorylated by the ThR complex and then bind to
SMAD4. The SMAD2/3–SMAD4 complex is translocated
into the nucleus to participate in an alteration of gene
expression (Heldin et al., 1997; Massague´, 1998). Previ-
ously, we examined the distribution pattern of TGF-h3,
ThRs, and SMADs in the developing palate to understand
the restriction of TGF-h3 signaling to the MEE in a278 (2005) 193–202
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Cui et al., 1998, 2003). We found that the expression pattern
of TGF-h3, receptors ThR-I and-II, and SMAD2 were
consistent. They were localized predominantly to the
epithelium covering the palatal shelves, which included
the palatal oral epithelium, palatal nasal epithelium, and
MEE before and during palatal shelf contact in the midline
(Cui and Shuler, 2000; Cui et al., 1998, 2003). Expression
of ThR-III (betaglycan) and SMAD2 phosphorylation,
however, was shown to be spatially restricted to the MEE
and temporally correlated with the disappearance of the
MEE during palatal fusion. Both ThR-III and phospho-
SMAD2 were present in the MEE immediately prior to
palatal shelf contact in the midline, and both retained an
exclusive distribution in the MEE as fusion progressed (Cui
and Shuler, 2000; Cui et al., 2003). The results suggested
that TGF-h3 exerted its developmental role in palatal fusion
in an autocrine manner through ThR-I and-II binding. The
role of ThR-III was hypothesized to localize and mediate
TGF-h3’s effect on MEE by specific presentation in the
MEE. As a consequence, SMAD2 phosphorylation was
spatially restricted to the MEE. In Tgf-h3/ mice, the
palate had a typical distribution of TGF-h1 and-h2 ligands
and receptors (Taya et al., 1999), however, no phosphory-
lated SMAD2 was identified in the MEE (Cui et al., 2003).
The absence of phospho-SMAD2 was correlated with the
persistence of the MEE and failure of palatal fusion in Tgf-
h3/ mice. The results suggested that TGF-h3 was
required for initiating and maintaining SMAD2 phosphor-
ylation in the MEE that was required for alterations in gene
expression necessary to complete palatal fusion. The
endogenous TGF-h1 and-h2 alone were unable to trigger
the SMAD2 phosphorylation to rescue the MEE fate in vivo
(Cui et al., 2003).
One strategy hypothesized to rescue the cleft palate
phenotype in Tgf-h3-deficient mice was to achieve MEE-
specific overexpression of Smad2 in the Tgf-h3/ MEE.
The Keratin 14 promoter driving Smad2 expression (K14-
Smad2) in the MEE appeared to be capable of providing
overexpression of Smad2 in the MEE. It has been shown
that in K14-Smad2 transgenic mice there was overexpres-
sion of Smad2 mRNA and translation of the Smad2 mRNA
into protein in Keratin 14-synthesizing epidermal cells (Ito
et al., 2001). The overexpressed SMAD2 was phosphory-
lated and translocated into the nucleus, regulated TGF-h
target gene expression, and triggered a positive feedback on
TGF-h signaling in a pathway-specific manner (Ito et al.,
2001). Keratin 14 has been shown to have high levels of
expression in the MEE in embryonic palatal epithelial sheet
cultured in vitro by immunohistochemistry (Carette et al.,
1991). We thus hypothesized that overexpression of K14-
Smad2 in the MEE of Tgf-h3-null mutants could rescue the
cleft palate phenotype via a positive induction of the TGF-h
signaling pathway. This approach would bypass an initial
requirement for TGF-h3 ligand binding to the TGF-h
receptors to initiate SMAD2 phosphorylation in the MEE.The goal of this study was to attempt rescue of the
cleft palate phenotype in the Tgf-h3/ mice by over-
expression of a Smad2 transgene in the MEE following
mating Tgf-h3 heterozygous mice (Tgf-h3tm1Doe) with
mice carrying the Smad2 transgene-driven by the K14
promoter (K14-Smad2).Materials and methods
Animals and genotyping
Tgf-h3tm1Doe heterozygous mice (Tgf-h3+/) had been
backcrossed for at least 12 generations onto the C57BL/6J
background (Jackson Laboratories, Bar Harbor, ME). Tgf-
h3+/ mice were bred to generate Tgf-h3/ newborns to
determine the palatal phenotype in highly backcrossed
C57BL/6J genetic background of the Tgf-h3 knockout
mice.
K14-Smad2 transgenic mice were generously provided
by Dr. Yang Chai (Ito et al., 2001). Tgf-h3tm1Doe hetero-
zygous mice were mated with K14-Smad2 mice to generate
a Tgf-h3+//K14-Smad2 line, which was then crossmated to
produce Tgf-h3//K14-Smad2 newborns to determine
whether MEE-directed overexpression of a Smad2 trans-
gene could rescue the cleft palate phenotype in Tgf-h3/
mice.
The genotype of the mice was determined by PCR using
genomic DNA extracted from tail biopsies of either adults or
newborns. Primers used to detect the Tgf-h3 knockout were
located in intron 5 and intron 6 of Tgf-h3 (Taya et al.,
1999). Primers used to detect the K14-Smad2 transgene
were designed to be specific for the K14 region (Ito et al.,
2001).
Fetuses obtained from timed pregnant C57BL/6J mice
were used to immunolocalize phospho-SMAD2 in the
developing palate. Fetuses were obtained between embry-
onic (E) days 14.5 and 15.5 as previously described (Cui
et al., 1998).
Assessment of palatal fusion
Newborn mice were collected immediately post partum.
Neonatal heads were immediately dissected. The jaw and
tongue were removed to evaluate both hard and soft palate
by direct observation with a dissecting microscope. Palatal
fusion was scored on a 0 to 13 point scale. The criteria for
this scale are as follows. (i) The nine rugae were used to
establish landmarks to locate specific fusion positions on
the palatal shelves (Sakamoto et al., 1991). The starting
and ending fusion points were documented by the position
of ruga. The total number of rugae fused was scored. For
example, if partial fusion starts at the 3rd ruga and ends at
the 5th ruga, the score is 3. There are a total of 9 points
equaling fusion at all 9 rugae that can be assigned for
fusion of the secondary hard palate. (ii) The pterygoid
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positions on the soft palate. Pterygoid plate can be
observed through the thin soft palatal mucous with a
dissecting microscope. Each 1/3 of pterygoid plate length
represents 1 point. There are a total of 3 points that can be
assigned for complete fusion of the soft palate. (iii) Fusion
of primary palate and secondary palate is assigned 1 point
(Fig. 1). Thus, a score of 0 represents complete cleft
palate, whereas a score of 13 represents complete palatal
fusion. All palatal fusion images were recorded by digital
camera for duplicate assessments prior to processing the
tissue for histological analysis.
Histological analysis
All neonatal heads were fixed in 10% buffered formalin
after they were assessed for palatal fusion. To confirm
palatal fusion at the histologic level, Tgf-h3//K14-Smad2
neonatal heads were embedded in paraffin. Coronal sections
(7 Am) were prepared serially from anterior to posterior and
processed for hematoxylin and eosin staining. Palatal fusion
was confirmed if there was an absence of epithelium
retained in the midline of palate.
Immunostaining
The embryonic heads were fixed in 4% paraformalde-
hyde-PBS at 48C, followed by routine procedures for
embedding in paraffin. Coronal or sagittal sections (6 Am)
were mounted in serial order on poly-l-lysine-coated slides.
The specific anti-phospho-SMAD2 (rabbit polyclonal IgG)
antibody was purchased from the Cell Signaling Technol-
ogy, Inc. (Beverly, MA). A Histostain kit (Zymed Labo-
ratories, Inc., South San Francisco, CA) was used to carry
out the immunohistochemical analysis as previously
described (Cui et al., 1998).Fig. 1. Image (left) and schematic diagram (right) of the palate of neonatal mouse a
positions on the hard palate. Rugae are numbered in anterioposterior sequence. Th
the soft palate. Pterygoid plate can be observed through the thin soft palatal muco
primary and secondary palates.Western blot analysis
To determine the levels of SMAD2 expression in the
Tgf-h3//K14-Smad2 mice, skin tissues were dissected
from the neonatal body and lysed with a boiling solution
containing SDS and 0.1 M DTT (Ito et al., 2001). One
hundred-microgram total protein per specimen was loaded
in each well on a 12% polyacrylamide gel. Electrophoresis
was carried out in a modular mini-Protean II electrophoresis
system (Bio-Rad, Hercules, CA). Protein was then trans-
ferred to a Millipore Immobilon-P membrane using a
Bio-Rad minitransblot electrophoretic transfer cell. The
subsequent Western blot was performed by using a
chemiluminescent Western blot kit (Boehringer Mannheim,
Indianapolis, IN). The primary antibody (mouse monoclonal
IgG) against SMAD2 (BD Transduction Laboratories, San
Diego, CA) or phospho-SMAD2 (Cell Signaling Technol-
ogy, Inc.) was incubated with the membrane overnight at
48C. The results were captured by Kodak X-Omat AR film
and measured by a computer image analysis program.
Correlation between phospho-SMAD2 protein level and
palate fusion was analyzed statistically by the Spearman
non-parametric method. The primary antibody (goat poly-
clonal IgG) against h-ACTIN (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA) was used as an internal control.Results
K14-Smad2 transgene rescues cleft palate in Tgf-b3/
mice
The hallmark of Tgf-h3/ mice is that they display
either complete cleft palate or severe partial cleft palate at
birth. The Tgf-h3/ pups die within 24 h of birth as they
could not successfully suckle (Kaartinen et al., 1995;t P0. The nine rugae are used to establish landmarks to locate specific fusion
e pterygoid plate is used as a landmark to locate specific fusion positions on
us (image on the left). Arrow (yellow color) indicates the site of fusion of
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determine if rescue of the cleft palate phenotype could be
achieved by overexpressing Smad2 in the MEE using the
K14 promoter to direct Smad2 expression. A Tgf-h3+//
K14-Smad2 line was generated by mating Tgf-h3+/ mice
(Tgf-h3tm1Doe) with K14-Smad2 mice. The Tgf-h3+//K14-
Smad2 mice retained the phenotype of the K14-Smad2
transgenic mice including features such as delayed hair
growth, underdeveloped ears and shorter tails (Ito et al.,
2001), but had no abnormality of the palate. Tgf-h3+//K14-
Smad2 mice were crossmated to generate Tgf-h3//K14-
Smad2 pups. Of 21 Tgf-h3//K14-Smad2 newborns
examined, all exhibited palatal fusion in the secondary hard
palate. The breeding line that generated the largest number
of offspring for analysis is specifically reported in greater
detail in the following section. This breeding pair produced
sufficient offspring for statistical analysis with a consistent
genetic background.
A total of 50 offspring from Tgf-h3+//K14-Smad2
crosses from one breeding pair were collected soon after
birth. The genotypes of all specimens were determined by
PCR. In particular, 11 specimens were Tgf-h3/, of which
6 were also positive for the K14-Smad2 transgene (Tgf-
h3//K14-Smad2) while the remaining Tgf-h3/ new-
borns were negative for the K14-Smad2 transgene (Tgf-
h3/). All Tgf-h3//K14-Smad2 and 4 of 5 Tgf-h3/
pups were alive at the time of collection. One Tgf-h3/
pup was found dead.
Tgf-h3//K14-Smad2 and Tgf-h3/ newborns were
assessed for palate fusion by direct observation with a
dissecting microscope. As shown in Table 1, 4 of 5 Tgf-
h3/ animals had complete cleft palate (Fig. 2A). One Tgf-
h3/ palate had a partial cleft with limited fusion betweenTable 1
Palatal fusion assessment
Genotype Sample no. Fusion score Description of palatal fusion
Tgf-h3/ a 0 No fusion
(complete cleft palate)
b 0 No fusion
(complete cleft palate)
c 0 No fusion
(complete cleft palate)
d 0 No fusion
(complete cleft palate)
e 4 Fusion between 3rd
and 6th ruga
Tgf-h3//
K14-Smad2
f 6 Fusion between 2nd
and 7th ruga
g 7 Fusion between 2nd
and 8th ruga
h 8 Fusion between 1st
and 8th ruga
i 10 Fusion between 1st ruga and
anterior 1/3 of soft palate
j 11 Fusion between 1st ruga and
middle 1/3 of soft palate
k 11 Fusion between 1st ruga and
middle 1/3 of soft palate
Fig. 2. Images (left) and schematic diagrams (right) of the palate of neonatal
mice at P0 to demonstrate various cleft palate/palatal fusion phenotypes.
(A) Tgf-h3/ newborn: complete cleft palate. (B and C) Tgf-h3//K14-
Smad2 newborns. (B) Rescue of palatal fusion (between arrows) is limited
between the 1st and 8th ruga of the secondary hard palate. The posterior
secondary palate remains unfused from the posterior border of the 9th ruga
to the entire soft palate. An anterior cleft is present at the junction between
the primary and secondary palate. (C) Rescue of palatal fusion (between
arrows) proceeds for the entire secondary hard palate and anterior portion of
the soft palate. The posterior soft palate, however, remains unfused. An
anterior cleft is present at the junction between the primary and secondary
palate. Arrow points anterior or posterior cleft.the 3rd and 6th ruga. In Tgf-h3//K14-Smad2 group, none
of the newborns had complete cleft palate. Instead, they all
exhibited palatal fusion with a minimum of 6 rugae range
(Table 1). Three of 6 Tgf-h3//K14-Smad2 newborns had
palatal fusion that proceeded for the entire secondary hard
palate and anterior portion of the soft palate. The posterior
soft palate, however, remained unfused (Fig. 2C). An
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the primary and secondary palate in Tgf-h3//K14-Smad2
mice (Figs. 2B and C).
Palatal fusion of Tgf-h3//K14-Smad2 neonatal mice
was verified microscopically by examining serial histologic
sections of the secondary palates. The results showed that in
sections from the 1st ruga region, the opposing palatal
shelves had not contacted in the midline either between each
other or between the palatal shelves and the nasal septum.
The palatal epithelium was intact (Fig. 3A). Palatal fusion is
normally complete at E16. No epithelium is identified in the
midline of secondary palate or at the junctions of the
primary and secondary palates after E16 (Kaufman, 1992).
The failure of palatal shelf fusion in the midline in the 1st
ruga region in Tgf-h3//K14-Smad2 specimens after birthFig. 3. Histology of partially rescued Tgf-h3//K14-Smad2 palate at P0
(H and E staining). (A) The opposing palatal shelves have no contact in the
midline either between each other or between the palatal shelves and the
nasal septum in the first ruga region. (B and C) The secondary palate is
fused with mesenchymal confluence and no epithelial midline seam. (B)
Anterior secondary hard palate. (C) Posterior secondary hard palate. n:
nasal septum. p: palatal shelf.is consistent with the failure of fusion between the primary
and secondary palate observed with a dissecting micro-
scope. The remainder of the secondary hard palate was
completely fused with mesenchymal confluence and no
epithelial midline seam (Figs. 3B and C). The absence of
epithelium in the midline of the intact secondary palate
confirms completion of secondary hard palatal fusion.
Palatal fusion outcomes correlate with the phospho-SMAD2
level
To determine if the improved palatal fusion in Tgf-h3//
K14-Smad2 newborns resulted from overexpression of the
Smad2 transgene, it was important to examine SMAD2 and
phospho-SMAD2 expression at the protein level and
correlate the protein level with the palate fusion outcomes.
Neonatal mice have passed the developmental stage that
demonstrated SMAD2 phosphorylation occurred in the MEE
during palatal fusion. Therefore, we used neonatal epidermis
as an alternative Keratin 14-synthesizing tissue to demon-
strate the SMAD2/phospho-SMAD2 level in Tgf-h3//
K14-Smad2 individuals by Western blot analysis (Ito et al.,
2001). As shown in Fig. 4A, Tgf-h3/ mice without the
K14-Smad2 transgene had little SMAD2 and very low levels
of phospho-SMAD2 production (Fig. 4A: a, b, c, d, e).
Correspondingly, the fusion scores were low (0–4 points)
(Fig. 4B). The Tgf-h3//K14-Smad2 counterparts, how-
ever, demonstrate higher levels of both SMAD2 and
phospho-SMAD2 in 4 of 6 specimens (Fig. 4A: g, i, j, k).
The specimens with the most prominent phospho-SMAD2
production (Fig. 4A: j, k) had the highest palatal fusion score
(11 points) (Fig. 4B). Correlation between the phospho-
SMAD2 level (normalized by the h-ACTIN protein level)
and the palatal fusion outcomes was further analyzed
statistically by the Spearman non-parametric method. The
result showed that the ranked palatal fusion score had a
statistically significant correlation with the normalized
phospho-SMAD2 quantities (P b 0.05). The result supported
the hypothesis that the palatal fusion outcome was correlated
with the phospho-SMAD2 level. The rescue of palatal fusion
in Tgf-h3 null mutants could be attributed to the elevated
phospho-SMAD2 level associated with the SMAD2 over-
expression generated by the K14-Smad2 transgene.
Phospho-SMAD2 is expressed in all regions of anticipated
palatal fusion in K14-Smad2 transgenic mice
K14-Smad2 transgene rescued cleft palate phenotype of
Tgf-h3-null mice. The rescue of palatal fusion was limited
to the secondary hard palate and the anterior 2/3 of the soft
palate (Table 1). Palatal fusion did not occur either at the
posterior soft palatal shelf region or between the primary
and secondary palates (Fig. 2C). A previous study has
suggested that heterogeneity existed along the anteriopos-
terior axis of the developing palate (Zhang et al., 2002). Our
conclusion regarding the transgene directed Smad2 over-
Fig. 4. Correlation of SMAD2/phospho-SMAD2 expression level with the palatal fusion outcomes. (A) Western blot analysis of expression of SMAD2 and
phospho-SMAD2 in epidermis in Tgf-h3/ mice with or without the K14-Smad2 transgene. (B) Plots of values of phospho-SMAD2 measurement
(normalized by the h-ACTIN level) and palatal fusion score versus sorted 11 Tgf-h3/ samples with or without the K14-Smad2 transgene.
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did not analyze palatal tissues. Therefore, the expression of
phospho-SMAD2 in the palate in K14-Smad2 mice was
analyzed by immunohistochemistry to determine whether
phospho-SMAD2 was expressed at all positions along the
palatal shelf required for palatal fusion. Special attention
was paid to the anterior and posterior extremities of the
secondary palate, regions not rescued by Smad2 over-
expression directed by K14 promoter.
Palatal fusion initially occurs in the middle region of the
palatal shelves at E14.5. The opposing palatal shelves
contact in the midline and form an epithelial seam. Both
anterior and posterior to this site, the shelves have yet to
become in contact (Kaufman, 1992). At this stage, phospho-
SMAD2 expression was exclusively localized to the MEE
and the palatal oral and nasal epithelium immediate adjacentto the midline seam (Figs. 5A–C). The nasal epithelium at
the base of nasal septum in the region of presumptive fusion
was also positive for phospho-SMAD2 staining (Fig. 5A).
The spatially restricted expression pattern of phospho-
SMAD2 in the palate in K14-Smad2 transgenic mice was
consistent with previous study on the wild-type animal (Cui
et al., 2003). At the identical concentration of anti-phospho-
SMAD2 antibody, the control animals did not have
detectable phospho-SMAD2 in the MEE (Figs. 5D and E).
The experimental conditions were controlled so that the
positive stains could be well detected in the MEE of the
transgenic specimens, but not in the tissues without K14-
Smad2 transgene as demonstrated in Fig. 5.
By E15.5, the palatal shelves have fused with each other,
and with the inferior border of the nasal septum. The
primary palate has begun to join the secondary palate and at
Fig. 5. Immunolocalization of phospho-SMAD2 in the palate in K14-Smad2 transgenic mice to demonstrate phospho-SMAD2 in all regions of palate. (A–E)
E14.5, coronal section, 20. (A–C) Transgenic tissues. (D and E) Non-transgenic tissues. (F) E15.5, sagittal section, 40, transgenic tissue. (A–C) E14.5.
Phospho-SMAD2 expression is exclusively localized to the MEE and the palatal oral and nasal epithelium adjacent to the midline seam of the palate. This
occurs both with respect to the in-fusion region (B) and the presumptive fusion regions that include anterior palate (A) and the posterior extremity of the palate
(C). The nasal epithelium at the base of nasal septum to be fused with palatal shelves is also positive with phospho-SMAD2 expression (A). (D and E) E14.5.
Phospho-SMAD2 expression is not detectable in either MEE or nasal epithelium in the littermate controls. (F) E15.5. Phospho-SMAD2 expression retains the
pattern observed in the E14.5 palate that is correlated with the formation and disruption of epithelial seams at the sites of fusion. Phospho-SMAD2 presents in
the region between the primary palate and the anterior extremity of the secondary palate (arrow). n: nasal septum. p: secondary palate. p1: primary palate.
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fusion region (Fig. 5F). Phospho-SMAD2 was present in all
regions that fuse in normal palatogenesis. The results
confirmed that K14 promoter was able to direct Smad2
gene overexpression and subsequent phosphorylation in the
MEE along the anterioposterior axis of the entire palate
immediately before and during palatal fusion. Failure of
rescue of the cleft palate phenotype in the anterior and
posterior extremities of the palate in the Tgf-h3//K14-
Smad2 animals was not due to heterogeneity of Smad2
expression directed by K14 promoter.
High occurrence of complete cleft palate in Tgf-b3tm1Doe
homozygous null mutants
An important control for these rescue experiments was to
determine the palatal phenotype in highly backcrossed
C57BL/6J genetic background of the Tgf-h3 null mutant
mice. Previously, this had not been determined (Kaartinen et
al., 1995; Proetzel et al., 1995) and it was critical to know
the background of palatal fusion in this mouse line. Weexamined Tgf-h3tm1Doe offspring at P0 to characterize the
developmental pattern of the palatal tissues. A total of 335
pups were collected immediately post partum. The expected
mendelian ratio of wild type, heterozygous and homozygous
offspring was obtained (24.2% Tgf-h3+/+, 51.6% Tgf-h3+/
and 24.2% Tgf-h3/ pups), indicating little prenatal
mortality. The result is consistent with previous reports
(Kaartinen et al., 1995; Proetzel et al., 1995).
Palatal fusion at P0 was evaluated by direct observation
with a dissecting microscope and histologic analysis of
serial sections. The results showed that 100% of Tgf-h3/
newborns (n = 81) had cleft secondary palate, 91.4% had a
complete cleft (74/81) while 8.6% partial cleft (7/81) (Table
2). In complete clefts, the bilateral palatal shelves were
separated from each other and the vomer was exposed to the
oral cavity. In partial cleft palate, fusion was limited to the
region between the 2nd and 5th ruga (Fig. 6A). Histological
examination confirmed that no epithelium was retained in
the midline fusion region. High penetrance of complete cleft
palate occurred in the highly backcrossed Tgf-h3 null
mutant mice with the C57BL/6J genetic background. The
Table 2
Occurrence of cleft palate in Tgf-h3tm1Doe newborns
Genotype Total sample no. Complete cleft Partial palate Anterior cleft
No. Ratio (%) No. Ratio (%) No. Ratio (%)
Tgf-h3/ 81 74 91.4 7 8.6 N/A N/A
Tgf-h3+/ 171 0 0 0 0 15 8.8
Tgf-h3+/+ 80 0 0 0 0 2 2.5
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regulation of palatal fusion and provided valuable back-
ground evidence in the Tgf-h3tm1Doe knockout mice for
analysis of genetic rescue of the cleft phenotype.
It was noted that 8.8% of the Tgf-h3+/ newborns (15/
171) and 2.5% of the Tgf-h3+/+ newborns (2/80) demon-
strated a failure of fusion between the primary and secondary
palates, namely anterior cleft (Fig. 6B, Table 2) (v2 test,
0.10 N P N 0.05). This type of cleft defect had not been
previously reported in any Tgf-h3+/ or Tgf-h3+/+ offspring
(Kaartinen et al., 1995; Proetzel et al., 1995). The phenotype
of the anterior cleft in Tgf-h3tm1Doe newborns (Fig. 6B) was
identical to the observation in Tgf-h3//K14-Smad2-
rescued newborns (Fig. 2C). Neither complete cleft nor
partial cleft secondary palate was detected in either Tgf-h3+/
(n = 171) or Tgf-h3+/+(n = 80) newborns (Table 2). These
detailed analyses provide a solid background for evaluating
the K14-Smad2 rescue of the Tgf-h3/ cleft palate and
demonstrate that overexpression does rescue the clefting.Discussion
The mammalian palate is formed by the union of three
elements: the primary palate from the frontonasal process
and the two lateral maxillary palatal shelves from the first
branchial arch that will form the secondary palate. PalatalFig. 6. Images of the palate of neonatal Tgf-h3tm1Doe mice at P0 to
demonstrate various cleft palate phenotypes. (A) Tgf-h3/: partial cleft
palate. Palatal fusion (between arrows) is limited between the 2nd and 5th
ruga. (B) Tgf-h3+/: an anterior cleft is present at the junction between the
primary and secondary palate (arrowhead).fusion involves three events. Laterally, the palatal shelves of
the maxillae (the future secondary palate) fuse across the
midline to form the roof of the oropharynx. Superiorly, the
palatal shelves in the midline fuse with the inferior border of
the nasal septum. In the anterior region, the anteromedial
borders of the palatal shelves fuse with the primary palate
(Kaufman, 1992). Palatal fusion is completed within a very
short period of time. During murine palatogenesis, palatal
fusion starts at E14.5 in the middle region of the shelves
(opposite the second to fourth pairs of rugae) and progresses
toward the posterior. Soon after, the superior and anterior
aspects of fusion take place. By E15.5, the fusion process is
virtually complete. The final region to close at about E16 is
close to the site where the primary and secondary palates
meet in the region of the incisive canal. Meanwhile, the
rugae associated with the mucosa on the oral surface of the
palate become more prominent at E16. A total of nine rugae
of various sizes are seen in the mouse (Kaufman, 1992;
Sakamoto et al., 1991; Shuler, 1995). Our scoring system
used to assess palatal fusion in the mice was established
based on the sequential events of palatal fusion.
Rescue of the cleft palate phenotype in the Tgf-h3-null
genetic background was attempted by a transgenic approach
conducted by cross-breeding Tgf-h3+/ mice (Tgf-h3tm1Doe)
with K14-Smad2 transgenic mice to produce Tgf-h3//
K14-Smad2 offspring. The results showed that the Tgf-h3/
offspring without Smad2 transgene retained the high inci-
dence of complete cleft palate as seen in the detailed analysis
of the cleft palate phenotype in the Tgf-h3tm1Doe homozygous
mutants. In contrast, the Tgf-h3/ mice with the Smad2
transgene driven by K14 promoter demonstrated a rescue of
palatal fusion. Two additional sets of results indicated that
success of rescue in Tgf-h3//K14-Smad2 mice was
dependent on an elevated level of phospho-SMAD2 in the
MEE. First, the Tgf-h3//K14-Smad2 individuals that
exhibited near complete palatal fusion had the highest
phospho-SMAD2 level in the Keratin 14-synthesizing
epidermis. Second, examination of E14.5-15.5 embryonic
mice demonstrated phospho-SMAD2 in the MEE in K14-
Smad2 mice. The non-K14-Smad2 transgenic control litter-
mates did not show phospho-SMAD2 in the MEE under the
same experimental condition. The results indicate that rescue
of palatal fusion in Tgf-h3-null mutants could be achieved
through the directed overexpression of SMAD2 in the MEE.
Previous research demonstrated that the overexpressed
SMAD2 in K14-Smad2 transgenic mice resulted in an
elevation of the endogenous TGF-h1 level, but did not
X.-M. Cui et al. / Developmental Biology 278 (2005) 193–202 201affect either the TGF-h2, TGF-h3, or Smad3 expression
levels (Ito et al., 2001). Correspondingly, overexpression of
Smad2 in the Tgf-h3/ genetic background should
increase TGF-h1 expression and consequently TGF-h1
signaling. It is possible that TGF-h1 functions to activate
SMAD2/phospho-SMAD2 and participates in the rescue of
the palatal fusion. Overexpression of Smad2 was thus able
to bypass an initial requirement for TGF-h3 ligand binding
to the TGF-h receptors to initiate SMAD2 phosphorylation
in the MEE.
It has been reported that in Tgf-h3/ mice there were
alterations with regard to the adhesion molecules in the
MEE (Tudela et al., 2002). In Tgf-h3+/+ palates, the
presence of associated E-cadherin, a- and h-catenin, and
h-actin were present circumferentially in the basal cells and
basolaterally in the superficial cells in the pre-adhesion
MEE. In Tgf-h3/ palate tissues, E-cadherin and a-catenin
were also located to apical regions of the MEE cells and h-
catenin was irregularly distributed in the cytoplasm. The
abnormal distribution of E-cadherin and E-cadherin asso-
ciated molecules in the Tgf-h3/MEE was correlated with
defect in the adhesion between opposing MEE and
subsequent failure of palatal fusion (Tudela et al., 2002).
A relationship between TGF-h1 signaling and adhesion
molecules has also been investigated (Miettinen et al., 1994;
Piek et al., 1999). TGF-h1 was able to induce epithelial–
mesenchymal transdifferentiation of a murine mammary
epithelial cell line NMuMG that was associated with a
change in cell morphology correlated with downregulation
and relocalization of E-cadherin and h-catenin, and SMAD2
phosphorylation with nuclear translocation (Miettinen et al.,
1994; Piek et al., 1999). These results suggest that TGF-h1-
inducted SMAD2 phosphorylation lead to changes in
adhesion during morphologic transdifferentiation of
NMuMG cells. Improved palatal fusion in the Tgf-h3//
K14-Smad2 mice may be linked to the downregulation/
relocalization of E-cadherin and associated molecules to the
apical surface of the Tgf-h3/ MEE, however, these
studies were not the subject of the current project.
In the present study, the rescue never proceeded either to
the junction of primary and secondary palates or the most
posterior border of the soft palate, despite phospho-SMAD2
presence in these regions at the same level as in the middle
portion of the secondary palate. This result suggests there
may be anterior–posterior patterning in the palatal shelves
and that additional mechanisms may be active at the most
anterior and posterior locations. TGF-h3 signaling may
accomplish more than just activation of SMAD2 to result in
the complete fusion of the palate in the most anterior and
posterior regions. The result further supports the notion that
TGF-h3 is a key initiator of the onset of the MEE
disappearance during palatal fusion (Cui et al., 2003) and
provides evidence that regional mechanisms might differ
between anterior and posterior segments of the palate.
Previous attempts to rescue the Tgf-h3/ cleft palate
phenotype were successful by supplement with additionalrecombinant TGF-h3 in vitro (Kaartinen et al., 1997; Taya
et al., 1999). However, the rescues of palatal fusion were
assessed only for the secondary palate. The fusion between
the primary palate and secondary palate was not assessed as
the organ culture system used in these studies excluded the
primary palate in the culture system. The most anterior and
posterior portions of the secondary palate were also not
assessed for palatal fusion due to the culture approach. The
conclusions reached from the rescue of palatal fusion in the
null mutants in vitro organ culture may be limited due to the
methodology.
In summary, the cleft palate phenotype in Tgf-h3/
mice could be rescued in vivo by overexpression of a
Smad2 transgene in the Keratin 14-synthesizing MEE cells
following mating Tgf-h3tm1Doe heterozygous mice with
K14-Smad2 transgenic mice. Success of the rescue could be
attributed to the elevated phospho-SMAD2 level in the
MEE. However, MEE-directed overexpression of Smad2 in
Tgf-h3 null mutants was not able to restore all the
functional outcomes of TGF-h3 signaling, since in all
cases, minor incomplete palatal fusion persisted at both the
junction of primary and secondary palates and in the most
posterior soft palate. The result supports the notion that
TGF-h3 is a key initiator of the onset of the MEE
disappearance during palatal fusion (Cui et al., 2003) and
provides evidence that regional mechanisms might differ
between anterior and posterior segments of the palate. Tgf-
h3/ mice without the Smad2 transgene had a high
incidence of complete cleft palate as seen in Tgf-h3tm1Doe
homozygous null mutant mice. This suggests that the
genetically homogenous Tgf-h3tm1Doe knockout model is
valuable model to study TGF-h3 function in the regulation
of the fate of the MEE during palatal fusion.Acknowledgments
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